Regression of diabetic complications by islet transplantation in the rat

Diabetologia

Volumn 52, Issue 12, 2009, Pages 2653-2661

  Remuzzi, A ^a,b   Cornolti, R ^a   Bianchi, R ^a   Figliuzzi, M ^a   Porretta Serapiglia, C ^a   Oggioni, N ^c   Carozzi, V ^c   Crippa, L ^c   Avezza, F ^c   Fiordaliso, F ^a   Salio, M ^a   Lauria, G ^d   Lombardi, R ^d   Cavaletti, G ^c  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF BERGAMO   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Cardiovascular disease; Diabetes; Islet transplantation; Nephropathy; Neuropathy

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); GLUCOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR DISEASE; CELL LOSS; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; ENZYME ACTIVITY; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY INJURY; MALE; MUSCLE CELL; NERVE CONDUCTION; NONHUMAN; PAIN THRESHOLD; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RAT; REMISSION; SCIATIC NERVE; STREPTOZOCIN DIABETES; TEMPERATURE SENSITIVITY; TREATMENT OUTCOME;

ANIMALS; BLOOD GLUCOSE; DIABETES COMPLICATIONS; DIABETIC NEUROPATHIES; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; NERVE FIBERS; NEURAL CONDUCTION; NOCICEPTORS; PAIN; QUALITY OF LIFE; RATS; RATS, INBRED LEW; SCIATIC NERVE; SODIUM-POTASSIUM-EXCHANGING ATPASE; TAIL; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TRANSPLANTATION, ISOGENEIC;

EID: 70949103630     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-009-1537-y     Document Type: Article

References (50)

1. A Fagot-Campagna I Bourdel-Marchasson D Simon 2005 Burden of diabetes in an aging population: prevalence, incidence, mortality, characteristics and quality of care Diabetes Metab 31 Spec No 2 5S35 5S52 16415764
2. EW Gregg MM Engelgau V Narayan 2002 Complications of diabetes in elderly people BMJ 325 916 917 10.1136/bmj.325.7370.916 12399324
3. G Said 2007 Diabetic neuropathy-a review Nat Clin Pract Neurol 3 331 340 10.1038/ncpneuro0504 17549059 (Pubitemid 46894936)
4. A Aneja WH Tang S Bansilal MJ Garcia ME Farkouh 2008 Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options Am J Med 121 748 757 10.1016/j.amjmed.2008.03.046 18724960
5. DCCT 1993 The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group N Engl J Med 329 977 986 10.1056/NEJM199309303291401 (Pubitemid 23307905)
6. AI Vinik TS Park KB Stansberry GL Pittenger 2000 Diabetic neuropathies Diabetologia 43 957 973 10.1007/s001250051477 10990072 (Pubitemid 30655714)
7. YM Hoybergs TF Meert 2007 The effect of low-dose insulin on mechanical sensitivity and allodynia in type I diabetes neuropathy Neurosci Lett 417 149 154 10.1016/j.neulet.2007.02.087 17412508 (Pubitemid 46551356)
8. HJ McQuay 2002 Neuropathic pain: evidence matters Eur J Pain 6 Suppl A 11 18 10.1053/eujp.2001.0316 11888235 (Pubitemid 40023564)
9. S Kiguchi T Imamura K Ichikawa M Kojima 2004 Oxcarbazepine antinociception in animals with inflammatory pain or painful diabetic neuropathy Clin Exp Pharmacol Physiol 31 57 64 10.1111/j.1440-1681.2004.03950.x 14756685 (Pubitemid 38230749)
10. ZY Fang JB Prins TH Marwick 2004 Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications Endocr Rev 25 543 567 10.1210/er.2003-0012 15294881 (Pubitemid 39096070)
11. A Frustaci J Kajstura C Chimenti, et al.. 2000 Myocardial cell death in human diabetes Circ Res 87 1123 1132 11110769
12. F Fiordaliso R Bianchi L Staszewsky, et al.. 2004 Antioxidant treatment attenuates hyperglycemia-induced cardiomyocyte death in rats J Mol Cell Cardiol 37 959 968 10.1016/j.yjmcc.2004.07.008 15522273 (Pubitemid 39446821)
13. NE Cameron MA Cotter V Archibald KC Dines EK Maxfield 1994 Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats Diabetologia 37 449 459 10.1007/s001250050131 8056181
14. R Bianchi B Buyukakilli M Brines, et al.. 2004 Erythropoietin both protects from and reverses experimental diabetic neuropathy Proc Natl Acad Sci U S A 101 823 828 10.1073/pnas.0307823100 14718663 (Pubitemid 38121042)
15. G Lauria M Morbin R Lombardi, et al.. 2003 Axonal swellings predict the degeneration of epidermal nerve fibers in painful neuropathies Neurology 61 631 636 12963753
16. NA Calcutt JD Freshwater JS O'Brien 2000 Protection of sensory function and antihyperalgesic properties of a prosaposin-derived peptide in diabetic rats Anesthesiology 93 1271 1278 10.1097/00000542-200011000-00021 11046216
17. E Leonelli R Bianchi G Cavaletti, et al.. 2007 Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis Neuroscience 144 1293 1304 10.1016/j.neuroscience.2006.11. 014 17187935 (Pubitemid 46123820)
18. CR Pierson W Zhang Y Murakawa AA Sima 2003 Insulin deficiency rather than hyperglycemia accounts for impaired neurotrophic responses and nerve fiber regeneration in type 1 diabetic neuropathy J Neuropathol Exp Neurol 62 260 271 12638730
19. DCCT 1995 The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group Ann Intern Med 122 561 568
20. P Fioretto MW Steffes DE Sutherland FC Goetz M Mauer 1998 Reversal of lesions of diabetic nephropathy after pancreas transplantation N Engl J Med 339 69 75 10.1056/NEJM199807093390202 9654536 (Pubitemid 28304880)
21. RW Gruessner DE Sutherland C Troppmann, et al.. 1997 The surgical risk of pancreas transplantation in the cyclosporine era: an overview J Am Coll Surg 185 128 144 10.1016/S1072-7515(01)00895-X 9249080
22. AM Shapiro JR Lakey EA Ryan, et al.. 2000 Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen N Engl J Med 343 230 238 10.1056/NEJM200007273430401 10911004 (Pubitemid 30490390)
23. N Kobayashi 2008 Bioartificial pancreas for the treatment of diabetes Cell Transplant 17 11 17 10.3727/000000008783907107 18468230
24. P Fiorina AM Shapiro C Ricordi A Secchi 2008 The clinical impact of islet transplantation Am J Transplant 8 1990 1997 10.1111/j.1600-6143.2008.02353.x 18828765
25. M Figliuzzi T Plati R Cornolti, et al.. 2006 Biocompatibility and function of microencapsulated pancreatic islets Acta Biomater 2 221 227 10.1016/j.actbio.2005.12.002 16701881 (Pubitemid 43230479)
26. LO Randall JJ Selitto 1957 A method for measurement of analgesic activity on inflamed tissue Arch Int Pharmacodyn Ther 111 409 419 13471093
27. G Cavaletti C Minoia M Schieppati G Tredici 1994 Protective effects of glutathione on cisplatin neurotoxicity in rats Int J Radiat Oncol Biol Phys 29 771 776 8040023
28. BF Scharschmidt EB Keeffe NM Blankenship RK Ockner 1979 Validation of a recording spectrophotometric method for measurement of membrane-associated Mg- and NaK-ATPase activity J Lab Clin Med 93 790 799 219124
29. G Lauria A Sghirlanzoni R Lombardi D Pareyson 2001 Epidermal nerve fiber density in sensory ganglionopathies: clinical and neurophysiologic correlations Muscle Nerve 24 1034 1039 10.1002/mus.1107 11439378 (Pubitemid 32656189)
30. MA Yorek LJ Coppey JS Gellett, et al.. 2002 Effect of treatment of diabetic rats with dehydroepiandrosterone on vascular and neural function Am J Physiol Endocrinol Metab 283 E1067 E1075 12376336
31. C Courteix A Eschalier J Lavarenne 1993 Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain Pain 53 81 88 10.1016/0304-3959(93)90059-X 8316394 (Pubitemid 23137271)
32. K Sugimoto IB Rashid M Shoji T Suda M Yasujima 2008 Early changes in insulin receptor signaling and pain sensation in streptozotocin-induced diabetic neuropathy in rats J Pain 9 237 245 10.1016/j.jpain.2007.10.016 18331706 (Pubitemid 351274070)
33. E Scarpini R Bianchi M Moggio M Sciacco MG Fiori G Scarlato 1993 Decrease of nerve Na+, K(+)-ATPase activity in the pathogenesis of human diabetic neuropathy J Neurol Sci 120 159 167 10.1016/0022-510X(93)90268-4 8138805 (Pubitemid 24040594)
34. T Brismar AA Sima DA Greene 1987 Reversible and irreversible nodal dysfunction in diabetic neuropathy Ann Neurol 21 504 507 10.1002/ana.410210515 2438993 (Pubitemid 17068552)
35. AA Sima 1996 Metabolic alterations of peripheral nerve in diabetes Semin Neurol 16 129 137 10.1055/s-2008-1040968 8987126
36. Y Kitano S Kuwabara S Misawa, et al.. 2004 The acute effects of glycemic control on axonal excitability in human diabetics Ann Neurol 56 462 467 10.1002/ana.20232 15455400 (Pubitemid 39319335)
37. G Devigili V Tugnoli P Penza, et al.. 2008 The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology Brain 131 1912 1925 10.1093/brain/awn093 18524793 (Pubitemid 351957452)
38. A Hirai H Yasuda M Joko T Maeda R Kikkawa 2000 Evaluation of diabetic neuropathy through the quantitation of cutaneous nerves J Neurol Sci 172 55 62 10.1016/S0022-510X(99)00290-7 10620661 (Pubitemid 30006982)
39. M Chattopadhyay C Walter M Mata DJ Fink 2009 Neuroprotective effect of herpes simplex virus-mediated gene transfer of erythropoietin in hyperglycemic dorsal root ganglion neurons Brain 132 879 888 10.1093/brain/awp014 19244253
40. RE Schmidt SB Plurad BJ Olack DW Scharp 1983 The effect of pancreatic islet transplantation and insulin therapy on experimental diabetic autonomic neuropathy Diabetes 32 532 540 10.2337/diabetes.32.6.532 6414860
41. AA Sima WX Zhang WJ Tze J Tai V Nathaniel 1988 Diabetic neuropathy in STZ-induced diabetic rat and effect of allogeneic islet cell transplantation. Morphometric analysis Diabetes 37 1129 1136 10.2337/diabetes.37.8.1129 3134264
42. CT Spadella JL Machado CA Caramori EA Gregorio 2002 Successful islet transplantation does not prevent the development of neuropathy in alloxan-induced diabetic rats Transplant Proc 34 1296 1300 10.1016/S0041- 1345(02)02769-0 12072345 (Pubitemid 34665346)
43. D Stroedter T Schmidt RG Bretzel K Federlin 1995 Glucose metabolism and left ventricular dysfunction are normalized by insulin and islet transplantation in mild diabetes in the rat Acta Diabetol 32 235 243 10.1007/BF00576256 8750762 (Pubitemid 26007465)
44. JJ Mourad S Le Jeune 2008 Blood pressure control, risk factors and cardiovascular prognosis in patients with diabetes: 30 years of progress J Hypertens 26 Suppl 3 S7 S14 10.1097/01.hjh.0000334601.93875.f8 18815515
45. D Giugliano A Ceriello G Paolisso 1995 Diabetes mellitus, hypertension, and cardiovascular disease: which role for oxidative stress? Metabolism 44 363 368 10.1016/0026-0495(95)90167-1 7885282
46. F Fiordaliso B Li R Latini, et al.. 2000 Myocyte death in streptozotocin-induced diabetes in rats is angiotensin II-dependent Lab Invest 80 513 527 10780668
47. M Tepel M van der Giet M Statz J Jankowski W Zidek 2003 The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial Circulation 107 992 995 10.1161/01.CIR.0000050628.11305.30 12600912 (Pubitemid 36258722)
48. J Brown AA Sima WJ Tze J Tai JA Thliveris 1989 The long-term effect of pancreatic islet allotransplantation on glomerular basement membrane thickening in experimental diabetes J Diabetes Complications 3 35 39 10.1016/0891-6632(89) 90008-1
49. K Ekberg T Brismar BL Johansson, et al.. 2007 C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy Diabetes Care 30 71 76 10.2337/dc06-1274 17192336 (Pubitemid 46061294)
50. CE Hills N Al-Rasheed GB Willars NJ Brunskill 2009 C-peptide reverses TGF-beta1-induced changes in renal proximal tubular cells: implications for treatment of diabetic nephropathy Am J Physiol Renal Physiol 296 F614 F621 10.1152/ajprenal.90500.2008 19091788